Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 172 followers
Latest posts
Last updated about 1 hour ago
Novo Nordisk’s chair to step down
about 1 hour ago
The chair of Novo Nordisk’s board is stepping down and will be...
Chemify raises $50M+ Series B to scale molecule-making business
about 2 hours ago
In Glasgow, Scotland, Lee Cronin is betting his startup can make molecules...
CRISPR Therapeutics says its new gene editing tool is 'a significant advance' over prime editing. Prime Medicine disagrees
about 3 hours ago
Breaking things is easier than fixing them, and so far, CRISPR Therapeutics...
Galapagos to exit cell therapy, with loss of 365 jobs and global sites to shutter
about 4 hours ago
Galapagos is to wind down its cell therapy division, saying it could...
'Decade of the ADCs' continues as AstraZeneca, Kelun and Merck present data at #ESMO25
about 5 hours ago
Two years ago at the European Society for Medical Oncology’s annual meeting...
Replimune resubmits melanoma drug for FDA approval
about 19 hours ago
Cancer biotech Replimune has resubmitted its melanoma drug for FDA approval after...
Summit plans to take ivonescimab to FDA, even with subpar OS data
about 19 hours ago
Summit Therapeutics says it will submit an application to the FDA by...
FDA staffing data show historic numbers of departures in fiscal 2025
about 20 hours ago
The FDA's drug and biologics centers saw nearly 1,000 net departures in...
Three drugs push CBO to raise orphan cost estimate to $8.8B over 10 years
about 20 hours ago
The Congressional Budget Office on Monday almost doubled its cost estimate for...
Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock sale
about 23 hours ago
Plus, news about Novo Nordisk, Amgen, AstraZeneca, Viridian Therapeutics, Alto Neuroscience and...
#ESMO25: Roche says ctDNA-guided Tecentriq prolonged survival in bladder cancer patients
about 23 hours ago
BERLIN — Roche presented Phase 3 data showing that adjuvant Tecentriq benefited...
RAPT, Jeyou are itching to start Phase 3 after encouraging mid-stage results in urticaria
about 23 hours ago
RAPT Therapeutics' partner Shanghai Jeyou Pharmaceutical intends to put the itch therapy...